Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...

Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative ...

THOUSAND OAKS, Calif., Nov. 25, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), a leading fully integrated next-generation gene therapy company developing treatments for rare and common ...

THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it ...

Nov. 12, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced new preclinical data for CAP-004, a potential best-in-class systemically administered next-generation gene therapy ...

Capsida Biotherapeutics is a fully integrated gene therapy company with a central nervous system (CNS) pipeline consisting of disease modifying and potentially curative treatments for rare and ...

THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it will ...